RC Outsourcing, LLC recalls Bevacizumab 1.75 mg/0.07 mL
- Published
- 15 Oct 2025
- Units affected
- 2,669 syringes
- Agency
- FDA
- Country
- United States
The hazard
Lack of assurance of sterility.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.
- Brand / company
- RC Outsourcing, LLC
- Codes / lots
- Lot # 20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025
- Distribution
- Nationwide in the US
- Recall status
- Terminated
Source: U.S. Food and Drug Administration, published 15 Oct 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.